US 9518090
Compositions and methods for treating hepatitis B
granted A61KA61K38/00A61K38/04
Quick answer
US patent 9518090 (Compositions and methods for treating hepatitis B) held by The Regents of the University of Colorado, a Body Corporate expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K38/00, A61K38/04, A61P, A61P31/20